AU592177B2 - Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same - Google Patents

Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same Download PDF

Info

Publication number
AU592177B2
AU592177B2 AU72275/87A AU7227587A AU592177B2 AU 592177 B2 AU592177 B2 AU 592177B2 AU 72275/87 A AU72275/87 A AU 72275/87A AU 7227587 A AU7227587 A AU 7227587A AU 592177 B2 AU592177 B2 AU 592177B2
Authority
AU
Australia
Prior art keywords
compound
amino
methyl
chloro
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU72275/87A
Other languages
English (en)
Other versions
AU7227587A (en
Inventor
Katsuhiko Hino
Tadahiko Karasawa
Shiro Kato
Tatsuya Kon
Toshiya Morie
Kazunori Ohno
Naoyuki Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of AU7227587A publication Critical patent/AU7227587A/en
Application granted granted Critical
Publication of AU592177B2 publication Critical patent/AU592177B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AU72275/87A 1986-04-30 1987-04-30 Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same Expired AU592177B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP61-101552 1986-04-30
JP10155286 1986-04-30
JP31509086 1986-12-31
JP61-315090 1986-12-31

Publications (2)

Publication Number Publication Date
AU7227587A AU7227587A (en) 1987-11-05
AU592177B2 true AU592177B2 (en) 1990-01-04

Family

ID=26442419

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72275/87A Expired AU592177B2 (en) 1986-04-30 1987-04-30 Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (1) US4870074A (enExample)
EP (1) EP0243959B1 (enExample)
KR (1) KR870010030A (enExample)
AR (1) AR242953A1 (enExample)
AU (1) AU592177B2 (enExample)
CA (1) CA1291135C (enExample)
CZ (1) CZ284687B6 (enExample)
DE (1) DE3781195T2 (enExample)
DK (1) DK175281B1 (enExample)
ES (1) ES2043617T3 (enExample)
FI (1) FI87776C (enExample)
GR (1) GR3005934T3 (enExample)
HK (1) HK18194A (enExample)
HU (1) HU198193B (enExample)
NZ (1) NZ220120A (enExample)
PH (1) PH24049A (enExample)
SK (1) SK289787A3 (enExample)
SU (1) SU1597101A3 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
TW213460B (enExample) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
EP0774460A1 (en) * 1994-03-30 1997-05-21 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compound and use thereof as medicine
NZ309065A (en) * 1995-05-23 1999-06-29 Janssen Pharmaceutica Nv (2-morpholinymethyl)benzamide derivatives having gastrointestinal motility stimulating properties
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
BR0114323A (pt) 2000-09-29 2003-07-01 Glaxo Group Ltd Composto ou um seu sal ou solvato farmaceuticamente aceitável, composição farmacêutica, uso do composto ou de um seu sal ou solvato farmaceuticamente aceitável, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar o composto
EP1353918B1 (en) * 2000-11-28 2005-01-12 Smithkline Beecham Plc Morpholine derivatives as antagonists of orexin receptors
JP4829417B2 (ja) * 2001-03-26 2011-12-07 明夫 乾 インスリン抵抗性改善薬
US20040265381A1 (en) * 2001-10-08 2004-12-30 Shanghvi Dilip S. Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
GB0208158D0 (en) * 2002-03-28 2002-05-22 Glaxo Group Ltd Novel compounds
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207447D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
HUP0201980A3 (en) * 2002-06-13 2008-06-30 Richter Gedeon Nyrt Process for preparing a benzamide derivative and intermediates thereof
CN1913876B (zh) * 2003-12-09 2013-06-26 大日本住友制药株式会社 含药物的颗粒和包含这种颗粒的固体制剂
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
PT2194053E (pt) * 2004-01-07 2013-07-08 Armetheon Inc Derivados de metoxipiperidina para utilização no tratamento de distúrbios gastrointestinais e do sistema nervoso central
TW200619212A (en) 2004-09-08 2006-06-16 Mitsubishi Pharma Corp Morpholine derivatives
WO2007002157A2 (en) 2005-06-23 2007-01-04 Array Biopharma Inc. Process for preparing benzimidazole compounds
DK1919909T3 (da) * 2005-08-31 2013-12-02 Armetheon Inc Syntesemetoder og mellemprodukter for stereoisomere forbindelser, der er anvendelige til behandling af gastrointestinale forstyrrelser og forstyrrelser i centralnervesystemet
WO2007075749A2 (en) * 2005-12-20 2007-07-05 Merck & Co., Inc. Niacin receptor agonists, compositions containing such compounds and methods of treatment
KR100750593B1 (ko) * 2006-03-16 2007-08-20 동우신테크 주식회사 치환된 벤즈아미드 유도체의 제조방법
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
AU2008242703B2 (en) * 2007-04-19 2011-08-18 Concert Pharmaceuticals Inc. Deuterated morpholinyl compounds
CN101402633A (zh) * 2007-09-11 2009-04-08 上海恒瑞医药有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
JP4989733B2 (ja) 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
CN102548542B (zh) 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
WO2011107903A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Highly pure mosapride citrate dihydrate and processes for its preparation
AU2012221927B2 (en) 2011-02-25 2016-04-28 Yuhan Corporation Diaminopyrimidine derivatives and processes for the preparation thereof
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN111349052B (zh) * 2020-04-07 2021-02-12 福建海西新药创制有限公司 一种枸橼酸莫沙必利的合成方法
CN114560822B (zh) * 2020-11-27 2024-05-28 鲁南制药集团股份有限公司 一种莫沙必利的二羧酸晶体
CN114591260B (zh) * 2020-12-05 2025-07-11 鲁南制药集团股份有限公司 一种莫沙必利有机酸盐
CN119241463A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法
CN119241464A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
US4323503A (en) * 1976-08-04 1982-04-06 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4210754A (en) * 1977-02-01 1980-07-01 Hoffmann-La Roche Inc. Morpholino containing benzamides
US4692445A (en) * 1983-04-29 1987-09-08 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPH0390274A (ja) * 1989-08-28 1991-04-16 Furukawa Alum Co Ltd Ａｌ又はＡｌ合金の気相ろう付法

Also Published As

Publication number Publication date
CA1291135C (en) 1991-10-22
PH24049A (en) 1990-03-05
DK218787D0 (da) 1987-04-29
CZ289787A3 (cs) 1998-11-11
DE3781195T2 (de) 1993-02-18
SK279058B6 (sk) 1998-06-03
DK175281B1 (da) 2004-08-09
FI87776B (fi) 1992-11-13
KR870010030A (ko) 1987-11-30
SK289787A3 (en) 1998-06-03
US4870074A (en) 1989-09-26
FI871828A7 (fi) 1987-10-31
DK218787A (da) 1987-10-31
FI871828A0 (fi) 1987-04-27
NZ220120A (en) 1989-06-28
HK18194A (en) 1994-03-11
AU7227587A (en) 1987-11-05
AR242953A1 (es) 1993-06-30
DE3781195D1 (de) 1992-09-24
FI87776C (fi) 1993-02-25
HUT45514A (en) 1988-07-28
EP0243959B1 (en) 1992-08-19
CZ284687B6 (cs) 1999-02-17
EP0243959A1 (en) 1987-11-04
SU1597101A3 (ru) 1990-09-30
ES2043617T3 (es) 1994-01-01
GR3005934T3 (enExample) 1993-06-07
HU198193B (en) 1989-08-28

Similar Documents

Publication Publication Date Title
AU592177B2 (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
KR100849569B1 (ko) 오렉신 수용체 길항제로 유용한 신규한 벤자제핀 및관련된 헤테로환형 유도체
US5281590A (en) 2-H and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides for the treatment of osteoporosis
SK15822002A3 (sk) Nové substituované diamínové deriváty použiteľné ako antagonisty motilínu
US5173486A (en) Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
US5288719A (en) 2-,3-,8-and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating osteoporosis
JPH07145057A (ja) 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
US5449674A (en) 2-,3-,5-, and/or 8-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain
US5441950A (en) Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use
WO1991010650A1 (en) Piperidine and pyrrolidine derivatives
HK1005029B (en) Dibenz [b,f] [1,4] oxazepin-11 (10h)-ones for multidrug resistance reversing agents
US5449675A (en) Substituted dibenzoxazepine and dibenzthiazepine urea compounds, pharmaceutical compositions and methods of use
US6127361A (en) 5,11-dihydrodibenzo[b,e][1,4]oxazepine derivatives and pharmaceutical compositions containing the same
US9605006B2 (en) 5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines
SK286977B6 (sk) Morfolínové deriváty, spôsob ich prípravy a farmaceutické prostriedky obsahujúce tieto zlúčeniny a ich použitie
US6528504B2 (en) Oxazepine derivatives and medicine containing the same
FI96024C (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyliglutarimidijohdannaisten valmistamiseksi
KR950008530B1 (ko) 치환된 벤즈아미드 유도체, 그 제조방법 및 이를 함유하는 약학적 조성물
US7320973B2 (en) Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same
DD256325A5 (de) Verfahren zur herstellung substituierter benzamidderivate